정맥 드레싱 시장 규모, 점유율, 동향 분석 : 유형별, 최종 용도별, 지역별 전망, 예측(2024-2031년)

The Global IV Dressing Market size is expected to reach $1.3 Billion by 2031, rising at a market growth of 5.9% CAGR during the forecast period. In the year 2023, the market attained a volume of 44,950.9 thousand units, experiencing a growth of 17.3% (2020-2023).

In 2023, the Asia Pacific region acquired a significant revenue share in the IV dressing market. The Asia Pacific region is seeing an upsurge in the frequency of chronic diseases like diabetes, cardiovascular disease, and cancer, owing primarily to urbanization, sedentary lifestyles, and changing dietary patterns. Therefore, the region is expected to generate 26.55% revenue share by 2031. Also, China would consume 6,159.7 thousand units of these dressings by 2031. The Asia Pacific region's economic expansion is causing governments and private sector organizations to invest more in enhancing healthcare infrastructure and broadening access to healthcare services, increasing healthcare spending.

Ambulatory care centers provide a wide range of medical treatments and procedures on an outpatient basis. Many of these procedures, such as infusion therapies, diagnostic tests, and minor surgeries, require IV access for medication administration. Therefore, the market is expanding significantly due to the expansion of ambulatory care centers. Additionally, Cancer patients frequently undergo chemotherapy or radiation therapy, which may require IV administration of chemotherapy drugs or supportive medications. Furthermore, cancer patients may require IV fluids or blood products to manage side effects such as dehydration or anemia. Thus, because of the growing prevalence of chronic diseases, the market is anticipated to increase significantly.

Moreover, The IV dressing market, like many other sectors of the healthcare industry, experienced disruptions in the supply chain due to lockdowns, travel restrictions, and logistical challenges caused by the pandemic. Manufacturers faced difficulties in sourcing raw materials, production delays, and distribution bottlenecks, leading to shortages of IV dressings in some regions. Also, The COVID-19 pandemic increased demand for IV therapy, notably in treating critically ill COVID-19 patients. IV therapy is crucial for administering fluids, medications, and other life-saving treatments to patients experiencing respiratory distress, dehydration, or complications from the virus. Thus, the COVID-19 pandemic had a moderate effect on the IV dressing market.

However, supply chain disruptions, like natural disasters, transportation delays, or manufacturing issues, can lead to shortages or stockouts. Healthcare institutions rely on a consistent supply of dressings to support patient care and treatment, and supply interruptions can disrupt clinical workflows, cause delays in procedures, and compromise patient safety. Thus, supply chain disruptions can slow down the growth of the market.

By Type Analysis

By type, the market is categorized as transparent and translucent. The translucent segment covered 25.23% considerable revenue share in the market in 2023 and in terms of volume the translucent segment consumes 8,418.6 thousand units in 2023. Translucent balance transparency and opacity, providing healthcare providers a partially clear view of the insertion site while offering some opacity for privacy and light protection. This versatility makes translucent dressings suitable for various clinical applications, driving their adoption across various healthcare settings. Translucent dressings are less noticeable on the skin than opaque dressings, providing a more aesthetically pleasing appearance for patients. The semi-transparent nature of translucent dressings allows for discreet monitoring of the insertion site while maintaining patient privacy and dignity, enhancing the overall patient experience.

By End-use Analysis

Based on end-use, the market is classified into hospitals, clinics, and others. The clinics segment acquired 32.13% revenue share in the market in 2023. In terms of volume, the clinics segment registered 13,373.8 thousand units in 2023. Clinics perform a wide range of outpatient procedures that require IV access for medication administration, fluid therapy, and diagnostic testing. As the trend towards outpatient care continues to grow, driven by convenience, cost-effectiveness, and advancements in medical technology, the demand for dressings in clinics rises accordingly.

By Regional Analysis

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2023, the North America region led the market by generating 40.93% revenue share. North America has a significant population affected by chronic diseases like diabetes, cardiovascular diseases, and cancer. North America boasts advanced healthcare infrastructure with well-established hospitals, clinics, and ambulatory care centers with state-of-the-art facilities and technologies. The aging population in North America contributes to the demand for healthcare services, including IV therapy.

List of Key Companies Profiled

• 3M Company
• Cardinal Health, Inc.
• Smith & Nephew PLC
• McKesson Corporation
• Covalon Technologies Ltd.
• Becton, Dickinson, and Company
• Molnlycke Health Care AB
• DermaRite Industries, LLC
• Dynarex Corporation
• Essity AB (BSN medical)

Global IV Dressing Market Report Segmentation

By Type (Volume, Thousand Units, USD Billion, 2020-2031)

• Transparent
• Translucent

By End-use (Volume, Thousand Units, USD Billion, 2020-2031)

• Hospitals
• Clinics
• Others

By Geography (Volume, Thousand Units, USD Billion, 2020-2031)

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1.Market Scope & Methodology

• 1.1Market Definition
• 1.2Objectives
• 1.3Market Scope
• 1.4Segmentation
  • 1.4.1Global IV Dressing Market, by Type
  • 1.4.2Global IV Dressing Market, by End-use
  • 1.4.3Global IV Dressing Market, by Geography
• 1.5Methodology for the research

Chapter 2.Market at a Glance

• 2.1Key Highlights

Chapter 3.Market Overview

• 3.1Introduction
  • 3.1.1Overview
    • 3.1.1.1Market Composition and Scenario
• 3.2Key Factors Impacting the Market
  • 3.2.1Market Drivers
  • 3.2.2Market Restraints
  • 3.2.3Market Opportunities
  • 3.2.4Market Challenges
• 3.3Porter's Five Forces Analysis

Chapter 4.Global IV Dressing Market by Type

• 4.1Global Transparent Market by Region
• 4.2Global Translucent Market by Region

Chapter 5.Global IV Dressing Market by End-use

• 5.1Global Hospitals Market by Region
• 5.2Global Clinics Market by Region
• 5.3Global Others Market by Region

Chapter 6.Global IV Dressing Market by Region

• 6.1North America IV Dressing Market
  • 6.1.1North America IV Dressing Market by Type
    • 6.1.1.1North America Transparent Market by Region
    • 6.1.1.2North America Translucent Market by Region
  • 6.1.2North America IV Dressing Market by End-use
    • 6.1.2.1North America Hospitals Market by Country
    • 6.1.2.2North America Clinics Market by Country
    • 6.1.2.3North America Others Market by Country
  • 6.1.3North America IV Dressing Market by Country
    • 6.1.3.1US IV Dressing Market
      • 6.1.3.1.1US IV Dressing Market by Type
      • 6.1.3.1.2US IV Dressing Market by End-use
    • 6.1.3.2Canada IV Dressing Market
      • 6.1.3.2.1Canada IV Dressing Market by Type
      • 6.1.3.2.2Canada IV Dressing Market by End-use
    • 6.1.3.3Mexico IV Dressing Market
      • 6.1.3.3.1Mexico IV Dressing Market by Type
      • 6.1.3.3.2Mexico IV Dressing Market by End-use
    • 6.1.3.4Rest of North America IV Dressing Market
      • 6.1.3.4.1Rest of North America IV Dressing Market by Type
      • 6.1.3.4.2Rest of North America IV Dressing Market by End-use
• 6.2Europe IV Dressing Market
  • 6.2.1Europe IV Dressing Market by Type
    • 6.2.1.1Europe Transparent Market by Country
    • 6.2.1.2Europe Translucent Market by Country
  • 6.2.2Europe IV Dressing Market by End-use
    • 6.2.2.1Europe Hospitals Market by Country
    • 6.2.2.2Europe Clinics Market by Country
    • 6.2.2.3Europe Others Market by Country
  • 6.2.3Europe IV Dressing Market by Country
    • 6.2.3.1Germany IV Dressing Market
      • 6.2.3.1.1Germany IV Dressing Market by Type
      • 6.2.3.1.2Germany IV Dressing Market by End-use
    • 6.2.3.2UK IV Dressing Market
      • 6.2.3.2.1UK IV Dressing Market by Type
      • 6.2.3.2.2UK IV Dressing Market by End-use
    • 6.2.3.3France IV Dressing Market
      • 6.2.3.3.1France IV Dressing Market by Type
      • 6.2.3.3.2France IV Dressing Market by End-use
    • 6.2.3.4Russia IV Dressing Market
      • 6.2.3.4.1Russia IV Dressing Market by Type
      • 6.2.3.4.2Russia IV Dressing Market by End-use
    • 6.2.3.5Spain IV Dressing Market
      • 6.2.3.5.1Spain IV Dressing Market by Type
      • 6.2.3.5.2Spain IV Dressing Market by End-use
    • 6.2.3.6Italy IV Dressing Market
      • 6.2.3.6.1Italy IV Dressing Market by Type
      • 6.2.3.6.2Italy IV Dressing Market by End-use
    • 6.2.3.7Rest of Europe IV Dressing Market
      • 6.2.3.7.1Rest of Europe IV Dressing Market by Type
      • 6.2.3.7.2Rest of Europe IV Dressing Market by End-use
• 6.3Asia Pacific IV Dressing Market
  • 6.3.1Asia Pacific IV Dressing Market by Type
    • 6.3.1.1Asia Pacific Transparent Market by Country
    • 6.3.1.2Asia Pacific Translucent Market by Country
  • 6.3.2Asia Pacific IV Dressing Market by End-use
    • 6.3.2.1Asia Pacific Hospitals Market by Country
    • 6.3.2.2Asia Pacific Clinics Market by Country
    • 6.3.2.3Asia Pacific Others Market by Country
  • 6.3.3Asia Pacific IV Dressing Market by Country
    • 6.3.3.1China IV Dressing Market
      • 6.3.3.1.1China IV Dressing Market by Type
      • 6.3.3.1.2China IV Dressing Market by End-use
    • 6.3.3.2Japan IV Dressing Market
      • 6.3.3.2.1Japan IV Dressing Market by Type
      • 6.3.3.2.2Japan IV Dressing Market by End-use
    • 6.3.3.3India IV Dressing Market
      • 6.3.3.3.1India IV Dressing Market by Type
      • 6.3.3.3.2India IV Dressing Market by End-use
    • 6.3.3.4South Korea IV Dressing Market
      • 6.3.3.4.1South Korea IV Dressing Market by Type
      • 6.3.3.4.2South Korea IV Dressing Market by End-use
    • 6.3.3.5Singapore IV Dressing Market
      • 6.3.3.5.1Singapore IV Dressing Market by Type
      • 6.3.3.5.2Singapore IV Dressing Market by End-use
    • 6.3.3.6Malaysia IV Dressing Market
      • 6.3.3.6.1Malaysia IV Dressing Market by Type
      • 6.3.3.6.2Malaysia IV Dressing Market by End-use
    • 6.3.3.7Rest of Asia Pacific IV Dressing Market
      • 6.3.3.7.1Rest of Asia Pacific IV Dressing Market by Type
      • 6.3.3.7.2Rest of Asia Pacific IV Dressing Market by End-use
• 6.4LAMEA IV Dressing Market
  • 6.4.1LAMEA IV Dressing Market by Type
    • 6.4.1.1LAMEA Transparent Market by Country
    • 6.4.1.2LAMEA Translucent Market by Country
  • 6.4.2LAMEA IV Dressing Market by End-use
    • 6.4.2.1LAMEA Hospitals Market by Country
    • 6.4.2.2LAMEA Clinics Market by Country
    • 6.4.2.3LAMEA Others Market by Country
  • 6.4.3LAMEA IV Dressing Market by Country
    • 6.4.3.1Brazil IV Dressing Market
      • 6.4.3.1.1Brazil IV Dressing Market by Type
      • 6.4.3.1.2Brazil IV Dressing Market by End-use
    • 6.4.3.2Argentina IV Dressing Market
      • 6.4.3.2.1Argentina IV Dressing Market by Type
      • 6.4.3.2.2Argentina IV Dressing Market by End-use
    • 6.4.3.3UAE IV Dressing Market
      • 6.4.3.3.1UAE IV Dressing Market by Type
      • 6.4.3.3.2UAE IV Dressing Market by End-use
    • 6.4.3.4Saudi Arabia IV Dressing Market
      • 6.4.3.4.1Saudi Arabia IV Dressing Market by Type
      • 6.4.3.4.2Saudi Arabia IV Dressing Market by End-use
    • 6.4.3.5South Africa IV Dressing Market
      • 6.4.3.5.1South Africa IV Dressing Market by Type
      • 6.4.3.5.2South Africa IV Dressing Market by End-use
    • 6.4.3.6Nigeria IV Dressing Market
      • 6.4.3.6.1Nigeria IV Dressing Market by Type
      • 6.4.3.6.2Nigeria IV Dressing Market by End-use
    • 6.4.3.7Rest of LAMEA IV Dressing Market
      • 6.4.3.7.1Rest of LAMEA IV Dressing Market by Type
      • 6.4.3.7.2Rest of LAMEA IV Dressing Market by End-use

Chapter 7.Company Profiles

• 7.13M Company
  • 7.1.1Company Overview
  • 7.1.2Financial Analysis
  • 7.1.3Segmental and Regional Analysis
  • 7.1.4Research & Development Expense
  • 7.1.5Recent strategies and developments:
    • 7.1.5.1Trials and Approvals:
  • 7.1.6SWOT Analysis
• 7.2Cardinal Health, Inc.
  • 7.2.1Company Overview
  • 7.2.2Financial Analysis
  • 7.2.3Segmental and Regional Analysis
  • 7.2.4SWOT Analysis
• 7.3Smith & Nephew PLC
  • 7.3.1Company Overview
  • 7.3.2Financial Analysis
  • 7.3.3Regional and Segmental Analysis
  • 7.3.4Research & Development Expense
  • 7.3.5SWOT Analysis
• 7.4McKesson Corporation
  • 7.4.1Company Overview
  • 7.4.2Financial Analysis
  • 7.4.3Segmental Analysis
  • 7.4.4Research & Development Expense
  • 7.4.5SWOT Analysis
• 7.5Covalon Technologies Ltd.
  • 7.5.1Company Overview
  • 7.5.2Financial Analysis
  • 7.5.3Research & Development Expenses
• 7.6Becton, Dickinson, and Company
  • 7.6.1Company Overview
  • 7.6.2Financial Analysis
  • 7.6.3Segmental and Regional Analysis
  • 7.6.4Research & Development Expense
  • 7.6.5SWOT Analysis
• 7.7Molnlycke Health Care AB
  • 7.7.1Company Overview
  • 7.7.2SWOT Analysis
• 7.8DermaRite Industries, LLC
  • 7.8.1Company Overview
  • 7.8.2SWOT Analysis
• 7.9Dynarex Corporation
  • 7.9.1Company Overview
  • 7.9.2SWOT Analysis
• 7.10.Essity AB (BSN medical)
  • 7.10.1Company Overview
  • 7.10.2Financial Analysis
  • 7.10.3Segmental and Regional Analysis
  • 7.10.4Research & Development Expenses
  • 7.10.5SWOT Analysis

Chapter 8.Winning Imperatives of IV Dressing Market